Convergen

Convergen is a startup based in China. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Convergen develops an artificial intelligence-powered platform that offers generative biological models, antibody design, target discovery, biomarker identification, and protein optimization to accelerate drug discovery for biotechnology and pharmaceutical companies.